Sudhamshi Toom, MD
Advertisement
Articles by Sudhamshi Toom, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
2
FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer
3
FDA ODAC Votes Yes to Capivasertib for PTEN-Deficient Metastatic HSPC
4
Targeting KRAS in Pancreatic Cancer: What Is Daraxonrasib’s Mechanism of Action?
5